These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17976024)

  • 1. Nanoimaging in protein-misfolding and -conformational diseases.
    Uversky VN
    Nanomedicine (Lond); 2007 Oct; 2(5):615-43. PubMed ID: 17976024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoimaging for protein misfolding diseases.
    Lyubchenko YL; Kim BH; Krasnoslobodtsev AV; Yu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):526-43. PubMed ID: 20665728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.
    Uversky VN; Kabanov AV; Lyubchenko YL
    J Proteome Res; 2006 Oct; 5(10):2505-22. PubMed ID: 17022621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
    Naiki H; Nagai Y
    J Biochem; 2009 Dec; 146(6):751-6. PubMed ID: 19643812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine and protein misfolding diseases.
    Kransnoslobodtsev AV; Shlyakhtenko LS; Ukraintsev E; Zaikova TO; Keana JF; Lyubchenko YL
    Nanomedicine; 2005 Dec; 1(4):300-5. PubMed ID: 16467913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein misfolding, functional amyloid, and human disease.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging the gap: from protein misfolding to protein misfolding diseases.
    Luheshi LM; Dobson CM
    FEBS Lett; 2009 Aug; 583(16):2581-6. PubMed ID: 19545568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation drives "misfolding" in protein amyloid fiber formation.
    Xu S
    Amyloid; 2007 Jun; 14(2):119-31. PubMed ID: 17577685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity.
    Stefani M
    Neuroscientist; 2007 Oct; 13(5):519-31. PubMed ID: 17901260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of amyloid formation.
    Härd T; Lendel C
    J Mol Biol; 2012 Aug; 421(4-5):441-65. PubMed ID: 22244855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for multiplex diagnostics and imaging.
    Wang L; O'Donoghue MB; Tan W
    Nanomedicine (Lond); 2006 Dec; 1(4):413-26. PubMed ID: 17716144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mysterious oligomerization of the amyloidogenic proteins.
    Uversky VN
    FEBS J; 2010 Jul; 277(14):2940-53. PubMed ID: 20546306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.